Title

Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.

Document Type

Journal Article

Publication Date

6-1-2016

Journal

Advances in Therapy

DOI

10.1007/s12325-016-0353-2

Peer Reviewed

1